Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
JHEP Rep
; 2(3): 100097, 2020 Jun.
Article
en En
| MEDLINE
| ID: mdl-32435753
AFP, alpha-fetoprotein; APHE, arterial phase hyperenhancement; BCS, Budd-Chiari syndrome; FNH, focal nodular hyperplasia-like; HBP, hepatobiliary phase; HCC; HCC, hepatocellular carcinoma; Imaging; LR, likelihood ratio; MRI; OATP, organic anionic transporting polypeptides; T1-w, T1-weighted imaging; TIPS, transjugular intrahepatic portosystemic shunt; WO, washout; liver cancer; non-invasive; tumor; vascular liver disease
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
JHEP Rep
Año:
2020
Tipo del documento:
Article
País de afiliación:
Francia
Pais de publicación:
Países Bajos